# MVX-ONCO-2 in Advanced Solid Tumors

> **NCT05071846** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital, Geneva** · enrollment: 6 (estimated)

## Conditions studied

- Solid Tumor, Adult

## Interventions

- **BIOLOGICAL:** MVX-ONCO-2

## Key facts

- **NCT ID:** NCT05071846
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-22
- **Primary completion:** 2026-11
- **Final completion:** 2029-10
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05071846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05071846, "MVX-ONCO-2 in Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05071846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*